May 09, 2021
Article
Protection from “natural infection” may last longer in older adults, authors say.
May 08, 2021
Patients who completed a 6 week rehabilitation program showed statistically significant improvement in exercise capacity, overall wellbeing and cognition.
May 07, 2021
Novavax plans to deliver approximately 350 million doses to COVAX during the third quarter of 2021.
The vaccine will now be included in WHO’s COVAX initiative, which is providing greater and more equitable access to vaccines around the world.
Reaching a vaccination rate of 50% by July of 2021 could prevent 5.8 million cases and 215,790 hospitalizations.
The companies are seeking approval for anyone aged 16 and above.
May 06, 2021
Company plans to initiate a rolling submission for US Food and Drug Administration (FDA) Biologics License Application (BLA) this month for the vaccine.
While the majority of COVID-19 patients made a full recovery, some still showed signs of reduced lung functioning during the study period.
Niclosamide, a common therapy for tapeworm infestation, has shown in lab studies to be highly effective against SARS-CoV-2.
Moderna reports data demonstrating a single 50 µg shot of its mRNA-1273 or mRNA-1273.351 booster shot increased neutralizing titers against SARS-CoV-2, as well as the South African and Brazilian variants.
